BCP Investment Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BCP Investment Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.49M | Mar 5, 2026 |
| FY2024 | Dec 31, 2024 | ($2.54M) | Mar 13, 2025 |
| FY2024 | Sep 30, 2024 | ($1.51M) | Mar 13, 2025 |
| FY2024 | Jun 30, 2024 | ($6.37M) | Mar 13, 2025 |
| FY2024 | Mar 31, 2024 | $4.49M | Mar 13, 2025 |
| FY2024 | Dec 31, 2023 | $7.00M | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | $7.45M | Mar 13, 2025 |
| FY2024 | Jun 30, 2023 | ($3.11M) | Mar 13, 2025 |
| FY2024 | Mar 31, 2023 | $55.0K | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($12.42M) | Mar 13, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.65M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $56.63M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $120.90M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | ($33.10M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $61.15M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $121.68M | Mar 9, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $523.64M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $453.63M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $549.24M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $619.49M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $648.30M | Mar 9, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $314.49M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $275.14M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $335.72M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $387.36M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $368.18M | Mar 9, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $209.16M | Mar 5, 2026 |
| FY2025 | Sep 30, 2025 | $231.30M | Mar 5, 2026 |
| FY2025 | Jun 30, 2025 | $164.73M | Mar 5, 2026 |
| FY2025 | Mar 31, 2025 | $173.51M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $178.49M | Mar 5, 2026 |
| FY2025 | Sep 30, 2024 | $187.98M | Mar 5, 2026 |
| FY2025 | Jun 30, 2024 | $196.43M | Mar 5, 2026 |
| FY2025 | Mar 31, 2024 | $210.61M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $213.52M | Mar 5, 2026 |
| FY2025 | Dec 31, 2022 | $232.12M | Mar 5, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($602.08M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($535.93M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($504.41M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($504.76M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($453.07M) | Mar 9, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.72M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $17.53M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $26.91M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $5.15M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $28.92M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $6.99M | Mar 9, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $306.88M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $265.14M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $322.41M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $373.31M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $347.19M | Mar 9, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 5, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Mar 13, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 5, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 13, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Mar 13, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.54M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 9.20M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | 9.38M | Mar 5, 2026 |
| FY2025 | Dec 31, 2022 | 9.58M | Mar 5, 2026 |
| FY2025 | Dec 31, 2021 | 9.70M | Mar 5, 2026 |
| FY2024 | Dec 31, 2020 | 7.52M | Mar 13, 2025 |
| FY2023 | Dec 31, 2019 | 4.48M | Mar 13, 2024 |
| FY2022 | Dec 31, 2018 | 3.73M | Mar 9, 2023 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.64M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $25.26M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $25.63M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $23.55M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $19.65M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $10.55M | Mar 9, 2023 |